Clinuvel Pharmaceuticals Market Cap

Clinuvel Pharmaceuticals has a market cap or net worth of 535.60 million as of May 16, 2025. Its market cap has decreased by -28.06% in one year.

Market Cap

535.60M

Enterprise Value

338.10M

Revenue

91.02M

Ranking

n/a

PE Ratio

13.92

Stock Price

10.71

Market Cap Chart

Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 535.60M, an increase of 10,149.50%. That is a compound annual growth rate of 21.02%.

Market Cap History

Date	Market Cap	% Change
May 15, 2025	541.61M	-10.09%
Dec 31, 2024	602.36M	-24.90%
Dec 29, 2023	802.04M	-25.09%
Dec 30, 2022	1.07B	-20.36%
Dec 31, 2021	1.34B	21.91%
Dec 31, 2020	1.10B	-21.55%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CSL Limited	116.12B
Pro Medicus	27.70B
Cochlear	17.60B
Sonic Healthcare	12.82B
Telix Pharmaceuticals	8.64B
Ramsay Health Care	8.29B
Ansell	4.72B
Regis Healthcare	2.33B

Market Cap Rankings